Recreating pathophysiology of CLN2 disease and demonstrating reversion by TPP1 gene therapy in hiPSCs-derived retinal organoid and retina-on-chip
Ontology highlight
ABSTRACT: Recreating pathophysiology of CLN2 disease and demonstrating reversion by TPP1 gene therapy in hiPSCs-derived retinal organoid and retina-on-chip
PROVIDER: PRJNA1022020 | ENA |
REPOSITORIES: ENA
ACCESS DATA